CONCLUSION
Despite the passage of time and advances in prevention and treatment, HIV/AIDS continues to affect many people around the world. Today’s younger people are living in a time when the disease is known to be controllable, and they may have limited knowledge about the history of HIV/AIDS and a lesser sense of urgency or concern about it. However, the public’s attitude toward the populations that are currently in the forefront of the epidemic remains one of stigmatization.
In the medical field, research has produced ever more effective drugs that slow the disease but do not stop it, and the cost of these drugs remains beyond the reach of many. No vaccine has proven effective in preventing HIV, and so the epidemic continues to spread, primarily among those high-risk persons living in disadvantaged and marginalized groups: the poor, people of color, people in prison, people who inject drugs, people who exchange sex for money or goods, and men who have sex with men. Many do not realize they are infected and may unknowingly transmit the virus to others.
The key to controlling this epidemic is prevention. Since most HIV infection is the result of sexual transmission, the most important prevention method is to refrain from unprotected sexual intercourse—vaginal, anal, or oral—unless it takes place within a monogamous relationship. The CDC recommends using latex condoms consistently and correctly and, when considering a sexual relationship, avoiding any type of sexual contact with someone who is unknown, is known to have had several sexual partners, or regularly uses syringes to inject drugs. Secondly, HIV is spread among injection drug users by the sharing of needles. Education and intervention must extend to these individuals to discourage the sharing of any type of drug paraphernalia.
Healthcare professionals have a vital role in meeting the goals for elimination of new HIV infections. These are built on the following key strategies:
- Educating patients, families, and communities about prevention
- Diagnosing all individuals with HIV as early as possible
- Treating people with HIV rapidly and effectively to achieve sustained viral suppression
- Preventing new HIV transmissions by using proven interventions, including pre-exposure prophylaxis and advocating for syringe services programs
- Providing compassionate and nondiscriminatory healthcare to those who have contracted this life-impacting disease
RESOURCES
AIDSinfo (USDHHS)
DC Health and Wellness Center (including TelePrEP)
202-741-7692
DC PEP Hotline: 202-299-3PEP (3737)
Emergency Contraception Hotline
888-NOT-2-LATE (888-668-2528)
HIV/AIDS (CDC)
HIV and AIDS (Office on Women’s Health)
HIV hotlines and referrals (CDC)
Sexual Being (DC Department of Health)
REFERENCES
NOTE: Complete URLs for references retrieved from online sources are provided in the PDF of this course.
AIDS Healthcare Foundation (AHF). (2019). HIV transmission. Retrieved from https://hivcare.org
Avert. (2020). Transmission fact sheet. Retrieved from https://www.avert.org
Avert. (2019). History of HIV and AIDS overview. Retrieved from https://www.avert.org
Avert. (2017). Prisoners, HIV and AIDS. Retrieved from https://www.avert.org
Cachay E. (2019). Human immunodeficiency virus (HIV) infection. Retrieved from https://www.merckmanuals.com
Centers for Disease Control and Prevention (CDC). (2020a). HIV and African American gay and bisexual men. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2020b). HIV risk behaviors. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2020c). HIV among women. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2020d). Getting HIV from needle use: less common ways. Retrieved from https://wwwn.cdc.gov
Centers for Disease Control and Prevention (CDC). (2020e). Viral load. Retrieved from https://wwwn.cdc.gov
Centers for Disease Control and Prevention (CDC). (2020f). Laboratory tests. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2020g). HIV testing. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019a). About HIV/AIDS. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019b). HIV surveillance report, 2018 (preliminary); vol. 30. Retrieved from http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
Centers for Disease Control and Prevention (CDC). (2019c). HIV by group. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019d). HIV and pregnant women, infants, and children. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019e). HIV transmission. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019f). STDS and HIV—CDC fact sheet. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019g). PEP. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019h). PrEP. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019i). Prescribe HIV prevention materials. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019j). Testing. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019k). Screening in clinical settings. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2017). HIV among incarcerated populations: fast facts. Retrieved from https://www.cdc.gov
Cohen M. (2019). HIV infection: risk factors and prevention strategies. UpToDate. Retrieved from https://www.uptodate.com
DC Health and Wellness Center. (2021). Retrieved from https://sexualbeing.org
District of Columbia Department of Health (DC Health), HIV/AIDS, Hepatitis, STD, & TB Administration. (2020). Annual epidemiology & surveillance report: data through December 2019. Retrieved from https://dchealth.dc.gov
Gillespie S. (2019). Diagnostic testing for HIV infection in infants and children younger than 18 months. UpToDate. Retrieved from https://www.uptodate.com
HIV Alliance. (2020). Risk assessment. Retrieved from https://hivalliance.org
HIV.gov. (2020a). U.S. statistics. Retrieved from https://www.hiv.gov
HIV.gov. (2020b). Impact on racial and ethnic minorities. Retrieved from https://www.hiv.gov
HIV.gov. (2018). Who should get tested? Retrieved from https://www.hiv.gov
Korobchuk A, Davtyan H, & Friedman S. (2019). People with high HIV viral load within risk networks: who are these people and who refers them best? J Infect Dev Ctries, 13(7), 103S–110S.
Kuhar D, Henderson D, Struble K, Heneine W, Thomas V, et al. (2018). Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. Retrieved from https://stacks.cdc.gov
Medicare.gov. (2020). HIV screenings. Retrieved from https://www.medicare.gov
National Clinician Consultation Center (NCCC). (2020). PEP: post-exposure prophylaxis. Retrieved from http://nccc.ucsf.edu
National Institute of Allergy and Infectious Diseases (NIAID). (2019). HIV/AIDS overview. Retrieved from https://www.niaid.nih.gov
National Institutes of Health (NIH). (2020). Less than a quarter of at-risk adolescent boys ever get tested for HIV. Retrieved from https://www.hiv.gov
Occupational Safety and Health Administration (OSHA). (n.d.). Occupational safety and health standard number 1910.103. Retrieved from https://www.osha.gov
Sax P. (2019). Screening and diagnostic testing for HIV infection. UpToDate. Retrieved from https://www.uptodate.com
Silvergleid A. (2019). Risk of HIV from blood transfusion. UpToDate. Retrieved from https://www.uptodate.com
United States Department of Health and Human Services (USDHHS). (2020). HIV fact sheets. Retrieved from https://aidsinfo.nih.gov
Waseem M. (2019). Body fluid exposures. Medscape. Retrieved from https://emedicine.medscape.com
Weibel S. (2018). Disparities in HIV healthcare: an expert perspective. Retrieved from https://www.hivlawandpolicy.org
Yamaguchi J, Vallari A, McArthur C, Sthreshley L, Cloherty G, et al. (2020). Complete genome sequence of CG-0018a-01 establishes HIV-1 Subtype L. JAIDS, 83(3), 319–22. doi:10.1097/QAI.0000000000002246